Strides Pharma Receives USFDA Approval for Fluoxetine, Expands Portfolio of Antidepressants
Strides Pharma Science Limited has announced that its step-down subsidiary, Strides Pharma Global Pte. Limited (Singapore), has secured approval from […]
Strides Pharma Science Limited has announced that its step-down subsidiary, Strides Pharma Global Pte. Limited (Singapore), has secured approval from […]
Strides Pharma Science has received a ‘Voluntary Action Indicated’ (VAI) classification from the U.S. Food and Drug Administration (USFDA) for […]
Strides Pharma Science on 8th January, 2019 announced that the company has decided to bring on board R Ananthanarayanan as […]
Strides Pharma Science has acquired 70 percent stake in a Switzerland-based Fairmed Healthcare AG for over 15.50 crore. The company’s […]